{
  "report": {
    "meta": {
      "report_id": "RPT-A",
      "generated_at": "2025-11-07T00:43:15.744314Z",
      "patient_id": null,
      "version": "1.0.0"
    },
    "sections": [
      {
        "id": "note_from_defiant",
        "title": "A Note from Defiant",
        "fields": {
          "provider_name": null,
          "provider_title": null,
          "provider_photo_url": null,
          "message": "We know waiting for answers can be stressful. This report summarizes what we\u2019ve learned so far and what comes next so you can feel informed and supported."
        }
      },
      {
        "id": "records_overview",
        "title": "Your Records",
        "fields": {
          "patient_name": "Alex Johnson",
          "date_of_review": "2025-11-06",
          "prepared_by": "Defiant Health",
          "sources_summary": "Medical records shared with Defiant Health as of 11/06/2025"
        },
        "records_received": [
          {
            "name": "Mammogram (Screening Bilateral)",
            "date_received": "2025-09-23"
          },
          {
            "name": "Ultrasound (Breast Left)",
            "date_received": "2025-10-02"
          },
          {
            "name": "Pathology Report",
            "date_received": "2025-10-10"
          }
        ],
        "notes": {
          "limitations": "We can only review the test results and doctor notes that were provided to us.",
          "disclaimer": "This report is for informational purposes and not medical advice."
        }
      },
      {
        "id": "diagnosis_summary",
        "title": "Your Diagnosis",
        "fields": {
          "primary_diagnosis": "Invasive Ductal Carcinoma",
          "diagnosis_summary": "Small tumor, no node involvement.",
          "date_of_diagnosis": "2025-10-10"
        },
        "tumors": [
          {
            "title": "Tumor 1",
            "cancer_type": "Invasive Ductal Carcinoma",
            "cancer_type_explanation": "Invasive ductal carcinoma (IDC) is the <strong>most common type of breast cancer.</strong> In simple terms, it started in the milk ducts (DCIS) and has now grown slightly outside of the ducts (IDC).",
            "location": "Left breast",
            "size_cm": 0.9,
            "location_explanation": "<strong>The tumor is small</strong>—less than a centimeter, or about the size of a dime. <strong>The initial tests show no signs of spread to the lymph nodes</strong>, which is often a positive sign for successful outcome for women who have a similar cancer profile.",
            "stage": "Stage I",
            "stage_explanation": "Stage I breast cancer is considered early-stage cancer. This means the tumor is small and has not spread to lymph nodes or other parts of the body, which is associated with a good prognosis.",
            "grade": "Grade 2",
            "grade_explanation": "The Nottingham Grade is a grading system used to describe how much the cancer cells look like normal cells and how quickly they are growing. Grade 2 is considered <strong>intermediate</strong>—not the slowest, but also not the fastest or most aggressive.",
            "hormoneReceptorStatus": "ER+/PR+, HER2-",
            "hormone_receptor_status_explanation": "Your cancer is <strong>hormone receptor positive</strong>, which means it is <strong>fueled by hormones</strong>. You can think of these hormones as \"food\" for the cancer cells. This means the primary, highly effective long-term treatment will be <strong>anti-hormone pills</strong> (endocrine therapy) to \"starve\" the cancer.",
            "her2Status": "ER+/PR+, HER2-",
            "her2_status_explanation": "Patients with HER2 negative status <strong>do not overproduce</strong> the HER2 protein and typically do not need the specific, targeted medications designed for HER2-positive cancer.",
            "laterality": "left",
            "source": {
              "type": "pathology",
              "date": "2025-10-10",
              "report_name": "Pathology Report",
              "report_id": null,
              "facility": null
            },
            "notes": "Findings are consistent with the diagnosis summary."
          }
        ],
        "whatThisMeans": {
          "goodNews": "We have a clear diagnosis and early treatment plan.",
          "newOptions": "Further testing or consultation may refine the plan.",
          "treatmentFocus": "Focus will be on targeted or endocrine therapy based on results.",
          "otherConsiderations": "Discuss final pathology and genetic testing with your oncologist."
        }
      },
      {
        "id": "next_steps",
        "title": "Next Steps",
        "description": "Follow-up actions and recommendations",
        "progressJourney": {
          "current_stage": "Diagnostic Testing",
          "stages": [
            {
              "name": "Diagnostic Testing",
              "status": "complete",
              "definition": null
            },
            {
              "name": "Planning",
              "status": "in_progress",
              "definition": null
            },
            {
              "name": "Treatment",
              "status": "pending",
              "definition": null
            }
          ]
        },
        "items": [
          {
            "name": "Oncotype DX",
            "date": null,
            "category": "Test",
            "status": "pending"
          },
          {
            "name": "Surgical Consultation",
            "date": "2025-11-10",
            "category": "Referral",
            "status": "scheduled"
          }
        ]
      },
      {
        "id": "treatment_planning",
        "title": "Your Likely Treatments",
        "fields": {
          "summary": "These are the most likely treatments based on your diagnosis and subtype.",
          "as_of_date": "2025-11-06",
          "source": "Defiant Health Pathways",
          "source_link": null,
          "disclaimer": null
        },
        "treatments": [
          {
            "name": "Endocrine Therapy",
            "description": "Tamoxifen for 5 years",
            "specialty": "medical oncology",
            "likelihood": "highly_likely"
          },
          {
            "name": "Lumpectomy",
            "description": "Breast-conserving surgery",
            "specialty": "surgical oncology",
            "likelihood": "highly_likely"
          }
        ],
        "clinical_trials": [],
        "disclaimer_footer": null
      },
      {
        "id": "oncologist_questions",
        "title": "Helpful Questions for Your Oncologist",
        "description": "Prompts to guide your next oncology visit.",
        "categories": [
          {
            "name": "Treatment Discussion",
            "questions": [
              {
                "text": "What are my main treatment options and their potential side effects?",
                "definition_terms": []
              },
              {
                "text": "How will my receptor status influence my treatment plan?",
                "definition_terms": []
              }
            ]
          }
        ],
        "footer_note": null
      },
      {
        "id": "care_team",
        "title": "Your Care Team",
        "items": [
          {
            "role": "Defiant Health Medical Team",
            "contact": "support@defianthealth.com"
          }
        ]
      },
      {
        "id": "footer",
        "title": "Report Footer",
        "fields": {
          "disclaimer": "This decision aid is not medical advice and does not replace discussions with your care team.",
          "contact_info": "Questions? Contact Defiant Health at support@defianthealth.com",
          "organization": "Defiant Health"
        }
      }
    ]
  }
}